Trupanion (NASDAQ:TRUP) Releases Earnings Results, Beats Estimates By $0.01 EPS

Trupanion (NASDAQ:TRUP) released its earnings results on Thursday. The financial services provider reported $0.02 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.01, Fidelity Earnings reports. The firm had revenue of $105.48 million during the quarter, compared to the consensus estimate of $104.92 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 2.08%.

Shares of Trupanion stock traded down $6.87 on Friday, hitting $29.40. 2,005,249 shares of the company traded hands, compared to its average volume of 329,537. The firm’s 50-day simple moving average is $33.90 and its 200 day simple moving average is $29.72. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.17. The company has a market cap of $1.19 billion, a P/E ratio of -326.67 and a beta of 1.76. Trupanion has a 12-month low of $20.84 and a 12-month high of $38.06.

In other news, CEO Darryl Rawlings sold 4,000 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $32.59, for a total transaction of $130,360.00. Also, insider Asher Bearman sold 1,600 shares of the firm’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $35.00, for a total transaction of $56,000.00. Following the sale, the insider now owns 2,360 shares in the company, valued at approximately $82,600. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 29,300 shares of company stock worth $1,007,207. Corporate insiders own 13.61% of the company’s stock.

A number of analysts recently commented on the stock. Raymond James cut shares of Trupanion from an “outperform” rating to a “market perform” rating in a research note on Friday. Zacks Investment Research upgraded shares of Trupanion from a “hold” rating to a “strong-buy” rating and set a $36.00 price target on the stock in a research note on Tuesday, January 14th. Canaccord Genuity restated a “buy” rating and set a $44.00 price target on shares of Trupanion in a research note on Friday. TheStreet upgraded shares of Trupanion from a “d+” rating to a “c-” rating in a research note on Tuesday, November 26th. Finally, Stifel Nicolaus cut shares of Trupanion from a “buy” rating to a “hold” rating and increased their target price for the stock from $32.00 to $38.00 in a research note on Wednesday, January 8th. Three analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $36.00.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Featured Article: What is the quiet period?

Earnings History for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.